GONAL-F RFF REDI-JECT

Follitropin · EMD Serono, Inc.

Drug timelines are a Plus or Pro feature.

14 regulatory and trial events tracked for GONAL-F RFF REDI-JECT, covering 2007-12-06 to 2024-05-13. Get the full timeline:

Most recent: FDA Approved: GONAL-F RFF REDI-JECT — Supplemental Application (EMD Serono, Inc.)